Literature DB >> 19933397

Insulin-regulated glucagon-like peptide-1 release from L cells: actin' out.

Debbie C Thurmond1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19933397      PMCID： PMC2795704          DOI： 10.1210/en.2009-1178

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  25 in total

1.  The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion.

Authors:  I R Jones; D R Owens; A J Moody; S D Luzio; T Morris; T M Hayes
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

2.  Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.

Authors:  M B Toft-Nielsen; M B Damholt; S Madsbad; L M Hilsted; T E Hughes; B K Michelsen; J J Holst
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

3.  Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus.

Authors:  E Mannucci; A Ognibene; F Cremasco; G Bardini; A Mencucci; E Pierazzuoli; S Ciani; A Fanelli; G Messeri; C M Rotella
Journal:  Diabet Med       Date:  2000-10       Impact factor: 4.359

4.  Insulin-stimulated GLUT4 translocation in adipocytes is dependent upon cortical actin remodeling.

Authors:  M Kanzaki; J E Pessin
Journal:  J Biol Chem       Date:  2001-09-06       Impact factor: 5.157

5.  Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.

Authors:  Mette Zander; Sten Madsbad; Jan Lysgaard Madsen; Jens Juul Holst
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

6.  Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.

Authors:  Bo Ahrén; Erik Simonsson; Hillevi Larsson; Mona Landin-Olsson; Hlin Torgeirsson; Per-Anders Jansson; Madeléne Sandqvist; Peter Båvenholm; Suad Efendic; Jan W Eriksson; Sheila Dickinson; David Holmes
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

7.  The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.

Authors:  T Vilsbøll; F K Knop; T Krarup; A Johansen; S Madsbad; S Larsen; T Hansen; O Pedersen; J J Holst
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

8.  Glucose-stimulated insulin secretion is coupled to the interaction of actin with the t-SNARE (target membrane soluble N-ethylmaleimide-sensitive factor attachment protein receptor protein) complex.

Authors:  Debbie C Thurmond; Carmen Gonelle-Gispert; Megumi Furukawa; Philippe A Halban; Jeffrey E Pessin
Journal:  Mol Endocrinol       Date:  2003-01-16

9.  Glucose regulates the cortical actin network through modulation of Cdc42 cycling to stimulate insulin secretion.

Authors:  Angela K Nevins; Debbie C Thurmond
Journal:  Am J Physiol Cell Physiol       Date:  2003-05-21       Impact factor: 4.249

10.  Insulin-induced actin filament remodeling colocalizes actin with phosphatidylinositol 3-kinase and GLUT4 in L6 myotubes.

Authors:  Z A Khayat; P Tong; K Yaworsky; R J Bloch; A Klip
Journal:  J Cell Sci       Date:  2000-01       Impact factor: 5.285
View more
  4 in total

1.  Gene targeting implicates Cdc42 GTPase in GPVI and non-GPVI mediated platelet filopodia formation, secretion and aggregation.

Authors:  Huzoor Akbar; Xun Shang; Rehana Perveen; Mark Berryman; Kevin Funk; James F Johnson; Narendra N Tandon; Yi Zheng
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

2.  Elevated circulating fasting glucagon-like peptide-1 in surgical patients with aortic valve disease and diabetes.

Authors:  Camilla Krizhanovskii; Stelia Ntika; Christian Olsson; Per Eriksson; Anders Franco-Cereceda
Journal:  Diabetol Metab Syndr       Date:  2017-10-10       Impact factor: 3.320

3.  Cellular biophysical dynamics and ion channel activities detected by AFM-based nanorobotic manipulator in insulinoma β-cells.

Authors:  Ruiguo Yang; Ning Xi; King Wai Chiu Lai; Kevin C Patterson; Hongzhi Chen; Bo Song; Chengeng Qu; Beihua Zhong; Donna H Wang
Journal:  Nanomedicine       Date:  2012-11-22       Impact factor: 5.307

4.  Glucagon-like peptide-1 secreting cell function as well as production of inflammatory reactive oxygen species is differently regulated by glycated serum and high levels of glucose.

Authors:  Alessandra Puddu; Roberta Sanguineti; Fabrizio Montecucco; Giorgio L Viviani
Journal:  Mediators Inflamm       Date:  2014-02-04       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.